These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 28323750)
1. Humoral responses against HIV in male genital tract: role in sexual transmission and perspectives for preventive strategies. Gagneux-Brunon A; Rochereau N; Botelho-Nevers E; Lucht F; Pozzetto B; Paul S; Bourlet T AIDS; 2017 May; 31(8):1055-1064. PubMed ID: 28323750 [TBL] [Abstract][Full Text] [Related]
2. Methods for evaluation of humoral immune responses in human genital tract secretions. Mestecky J; Alexander RC; Wei Q; Moldoveanu Z Am J Reprod Immunol; 2011 Mar; 65(3):361-7. PubMed ID: 21087333 [TBL] [Abstract][Full Text] [Related]
3. Antibody-Based Preventive and Therapeutic Strategies Against HIV. Fabra-Garcia A; Beltran C; Sanchez-Merino V; Yuste E Curr HIV Res; 2016; 14(3):260-9. PubMed ID: 26957200 [TBL] [Abstract][Full Text] [Related]
4. Humoral immune responses to the human immunodeficiency virus type-1 (HIV-1) in the genital tract compared to other mucosal sites. Mestecky J J Reprod Immunol; 2007 Feb; 73(1):86-97. PubMed ID: 17354294 [TBL] [Abstract][Full Text] [Related]
5. Immunologic uniqueness of the genital tract: challenge for vaccine development. Mestecky J; Moldoveanu Z; Russell MW Am J Reprod Immunol; 2005 May; 53(5):208-14. PubMed ID: 15833098 [TBL] [Abstract][Full Text] [Related]
6. Immunization with HIV-1 gp41 subunit virosomes induces mucosal antibodies protecting nonhuman primates against vaginal SHIV challenges. Bomsel M; Tudor D; Drillet AS; Alfsen A; Ganor Y; Roger MG; Mouz N; Amacker M; Chalifour A; Diomede L; Devillier G; Cong Z; Wei Q; Gao H; Qin C; Yang GB; Zurbriggen R; Lopalco L; Fleury S Immunity; 2011 Feb; 34(2):269-80. PubMed ID: 21315623 [TBL] [Abstract][Full Text] [Related]
7. Humoral immune responses to the human immunodeficiency virus type-1 (HIV-1) in the genital tract compared to other mucosal sites. Mestecky J J Reprod Immunol; 2006 Dec; 72(1-2):1-17. PubMed ID: 17095369 [TBL] [Abstract][Full Text] [Related]
8. [Anti-HIV antibodies: multiple antiviral activities]. Peressin M; Holl V; Moog C Med Sci (Paris); 2014 Jan; 30(1):69-75. PubMed ID: 24472462 [TBL] [Abstract][Full Text] [Related]
9. Maternal Binding and Neutralizing IgG Responses Targeting the C-Terminal Region of the V3 Loop Are Predictive of Reduced Peripartum HIV-1 Transmission Risk. Martinez DR; Vandergrift N; Douglas AO; McGuire E; Bainbridge J; Nicely NI; Montefiori DC; Tomaras GD; Fouda GG; Permar SR J Virol; 2017 May; 91(9):. PubMed ID: 28202762 [TBL] [Abstract][Full Text] [Related]
10. Short Communication: Exploring Antibody Potential as Prophylactic/Therapeutic Strategies for Prevention of Early Mucosal HIV-1 Infection. Su B; Peressin M; Ducloy C; Penichon J; Mayr LM; Laumond G; Schmidt S; Decoville T; Moog C AIDS Res Hum Retroviruses; 2015 Nov; 31(11):1187-91. PubMed ID: 26252799 [TBL] [Abstract][Full Text] [Related]
11. Are anti-HIV IgAs good guys or bad guys? Zhou M; Ruprecht RM Retrovirology; 2014 Dec; 11():109. PubMed ID: 25499540 [TBL] [Abstract][Full Text] [Related]
12. Maternal Humoral Immune Correlates of Peripartum Transmission of Clade C HIV-1 in the Setting of Peripartum Antiretrovirals. Mutucumarana CP; Eudailey J; McGuire EP; Vandergrift N; Tegha G; Chasela C; Ellington S; van der Horst C; Kourtis AP; Permar SR; Fouda GG Clin Vaccine Immunol; 2017 Aug; 24(8):. PubMed ID: 28566336 [TBL] [Abstract][Full Text] [Related]
13. Mucosal immunization with inactivated HIV-1-capturing nanospheres induces a significant HIV-1-specific vaginal antibody response in mice. Akagi T; Kawamura M; Ueno M; Hiraishi K; Adachi M; Serizawa T; Akashi M; Baba M J Med Virol; 2003 Feb; 69(2):163-72. PubMed ID: 12683403 [TBL] [Abstract][Full Text] [Related]
14. Antibody-mediated immune exclusion of HIV. Ruprecht RM; Lakhashe SK Curr Opin HIV AIDS; 2017 May; 12(3):222-228. PubMed ID: 28422786 [TBL] [Abstract][Full Text] [Related]
15. Inflammation and HIV Transmission in Sub-Saharan Africa. Kaul R; Prodger J; Joag V; Shannon B; Yegorov S; Galiwango R; McKinnon L Curr HIV/AIDS Rep; 2015 Jun; 12(2):216-22. PubMed ID: 25877253 [TBL] [Abstract][Full Text] [Related]
16. Broadly Neutralizing Antibodies Against HIV: New Insights to Inform Vaccine Design. Sadanand S; Suscovich TJ; Alter G Annu Rev Med; 2016; 67():185-200. PubMed ID: 26565674 [TBL] [Abstract][Full Text] [Related]
17. Neutralizing activity and cellular immune responses induced in mice after immunization with apoptotic HIV-1/murine leukemia virus infected cells. Hinkula J; Walther-Jallow L; Laurén A; Mäkitalo B; Oberg M; Wahren B; Fenyö EM; Spetz AL Vaccine; 2009 Oct; 27(46):6424-31. PubMed ID: 19549607 [TBL] [Abstract][Full Text] [Related]
18. Inhibitory Effect of Individual or Combinations of Broadly Neutralizing Antibodies and Antiviral Reagents against Cell-Free and Cell-to-Cell HIV-1 Transmission. Gombos RB; Kolodkin-Gal D; Eslamizar L; Owuor JO; Mazzola E; Gonzalez AM; Korioth-Schmitz B; Gelman RS; Montefiori DC; Haynes BF; Schmitz JE J Virol; 2015 Aug; 89(15):7813-28. PubMed ID: 25995259 [TBL] [Abstract][Full Text] [Related]
19. Mucosa: Key Interactions Determining Sexual Transmission of the HIV Infection. Gonzalez SM; Aguilar-Jimenez W; Su RC; Rugeles MT Front Immunol; 2019; 10():144. PubMed ID: 30787929 [TBL] [Abstract][Full Text] [Related]
20. Induction of innate immune responses in the female genital tract: friend or foe of HIV-1 infection? Firoz Mian M; Ashkar AA Am J Reprod Immunol; 2011 Mar; 65(3):344-51. PubMed ID: 21223417 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]